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Abstract: The Impella recover LP 2.5 is a percutaneous left ventricular assist device (LVAD) recently approved for use in patients 
undergoing high risk percutaneous coronary intervention (PCI) and also in cases of cardiogenic shock. There is limited evidence 
available in literature about its safety, especially with regards to the incidence of local vascular complications, their management and 
long-term implications. We report here the first case of a serious local vascular complication—superficial femoral artery thrombus 
formation during Impella recover LP 2.5 use in a high risk PCI which was managed successfully with novel aspiration thrombectomy 
catheter (Pronto V3), which in itself is the first reported use of Pronto V3 in such a vascular complication.
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case Report
An 86 year old lady with a past medical history of 
hypertension,  diabetes  mellitus,  hypothyroidism, 
Bell’s  palsy,  transient  ischemic  attack,  hypercho-
lesterolemia, Parkinson’s  disease,  abdominal   aortic 
aneurysm repair, peripheral vascular disease, stage IV 
chronic kidney disease, renal artery stents, coronary 
artery disease with a history of drug eluting stents to the 
right coronary and left circumflex arteries and diastolic 
heart failure was admitted to our hospital with severe 
chest pain. This was her second admission for unstable 
angina in the past three weeks. She also suffered two 
non-ST segment myocardial infarctions (NSTEMI) in 
the past three weeks. During all her previous admis-
sions she was considered a high-risk candidate for 
any invasive therapy due to multiple co-morbidities 
and hence was managed   medically. However, on this 
occasion the patient agreed to a coronary angiogram. 
She  was  found  to  have  left  main  and  triple  ves-
sel  coronary  artery  disease.  The  coronary  lesions 
were as follows: There was a diffuse 60% stenosis 
of  distal  third  of  left  main  coronary  artery.  The 
left  anterior  descending  artery  (LAD)  revealed  an 
80% stenosis at the ostium followed by 70% stenosis 
of mid portion. The proximal left circumflex artery 
was medium sized with a patent previous stent. The 
first  obtuse  marginal  showed  tubular  70%  steno-
sis  in  the  middle  third  of  the  vessel  segment. 
There was also a discrete 70% stenosis in the ostial 
right  coronary  artery  (RCA)  and  70%  stenosis  of 
mid  RCA.  The  left  ventricular  ejection  fraction 
by  echocardiography  was  35%–50%  with  anterior 
and  anterolateral  hypokinesis.  Distal  abdominal 
aortography with bilateral run-off revealed no sig-
nificant  aorto-iliac  disease.  Different  modalities  of 
treatment  were  discussed  with  the  patient  and  her 
family. She was deemed a poor candidate for surgery 
and the only options were high risk PCI or medical 
management. The patient did not agree to surgery 
or PCI and was managed with aggressive medical 
treatment.  She  was  readmitted  within  two  weeks 
for  another  episode  of  unstable  angina  and  acute 
NSTEMI. Having failed medical therapy, she agreed 
to undergo high risk PCI. A multi-vessel PCI of Left 
main into LAD and possibly of ostial right coronary 
artery and obtuse marginal was planned.
The Impella recover LP 2.5 LVAD was chosen for 
circulatory support during this high-risk procedure. 
After obtaining adequate arterial access and insertion 
of appropriate sheaths, the Impella 2.5 device was 
placed in the left ventricular cavity via the left com-
mon femoral artery (CFA) sheath, under fluoroscopy 
and  adequate  flow  ensured. A  cine  run  of  the  left 
ilio-femoral system was performed before and after 
insertion of the sheath. There was some sluggish flow 
noted  in  the  left  superficial  femoral  artery  (SFA). 
At this time a decision was made to only perform a 
left main and LAD intervention and stage the other 
lesions.  Using  right  CFA  access,  a  Balloon  angio-
plasty and bare metal stenting were performed on the 
left main and mid LAD lesions with excellent angio-
graphic  appearance  and  0%  residual  stenosis.  The 
Left circumflex ostium was not compromised angio-
graphically. The Impella device was removed as per 
protocol. Another cine run of the left ilio-femoral sys-
tem was performed. This revealed extremely sluggish 
flow in the left SFA with the appearance of multiple 
thrombi like lesions throughout its course. The left 
leg clinically appeared to be cooler than the right. The 
13 French (Fr) Impella device sheath was removed 
and hemostasis achieved successfully with Perclose
®. 
A 6 Fr multipurpose catheter was placed via the right 
CFA sheath into left common iliac and a selective 
Figure 1. Pre-procedure angiogram showing patent superficial femoral 
artery.Complication of Impella managed with pronto
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angiogram  of  the  left  common  iliac,  external  iliac 
and  common  femoral  arteries  was  obtained.  This 
confirmed our previous findings with better delinea-
tion of the thrombus like lesions along the length of 
the SFA. Two inflations of the CFA at the site of Per-
close sutures was performed with a 4.0 × 20 mm Fox 
plus balloon with 10 atmospheres of pressure. Flow 
in the superficial femoral artery remained sluggish. 
The patient had developed an acutely ischemic limb 
secondary  to  cessation  of  antegrade  flow  down 
the left superficial femoral artery. Time was of the 
essence. We did have the angiojet device commonly 
used for thrombectomy procedures. However set up 
of this device is a little time consuming. The pronto 
extraction catheter is another device commonly used 
for thrombus extraction with very little set up time. 
This was readily available and in our experience has 
shown tremendous success in thrombus extraction in 
coronary cases. Hence we decided to use this device 
while the angiojet was being set up. An aspiration 
thrombectomy was then performed using Pronto V3 
extraction  catheter.  The  angiographically  apparent 
thrombi were completely removed with 0% remain-
ing stenosis. The flow in the left CFA returned to 
normal. Good peripheral circulation was confirmed 
clinically. Hence we decided to stop at this point and 
did not go ahead with use of the angiojet device. The 
patient was transferred to CCU for observation and 
did well hemodynamically. Her post procedure period 
was complicated by acute kidney injury in the face 
of chronic kidney disease, requiring hemodialysis for 
two sessions three days apart. The kidney function 
and urine output returned to baseline two weeks after 
the procedure. The patient was discharged in stable 
condition  for  physical  rehabilitation.  Four  months 
after the procedure, the patient remains angina free 
and has not been readmitted since.
Discussion
Mechanical assist devices have found a growing role 
in high risk PCI due to an increasing patient popu-
lation with complex co-morbidities, most of whom 
are not good candidates for surgery. Impella recover 
LP 2.5 is the first percutaneous left ventricular assist 
devices  currently  available.  It  is  inserted  via  a  13 
French sheath and placed under fluoroscopic guid-
ance in the left ventricular cavity. The device is capa-
ble of providing 2.5 Litres/minute of blood flow and 
thus ensures a stable cardiac output. Successful use 
of the Impella as a circulatory support device in high 
Figure 2. post sheath removal angiogram showing absence of blood 
flow in superficial femoral artery.
Figure 3. Post Pronto V3 device use, showing resumption of blood flow 
in superficial femoral artery.Bhat et al
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risk PCI was initially reported from Europe.1 It has 
also  been  used  in  patients  with  cardiogenic  shock 
either alone or in combination with other devices like 
intraaortic balloon pump.2,3 This device can be main-
tained in situ for five to seven days and was recently 
approved for use in the USA by FDA for partial cir-
culatory support up to six hours.
Published literature on the use of Impella device, 
including  safety  is  limited.  Reported  complica-
tions  associated  with  the  Impella  device  include 
sensor failure, pump displacement, hemolysis and 
functional mitral stenosis.2,4 It is thought that due 
to the use of a larger sheath (13Fr), there may be 
increased incidence of local vascular complications 
including bleeding and limb ischemia but has not 
been observed in the published experience. Recent 
large multi-centre registries from Europe and pre-
vious small feasibility trials have not reported any 
major local vascular complication especially limb 
ischemia.5–7
In  our  case,  the  Impella  device  was  used  in  a 
patient with triple vessel coronary artery disease and 
left ventricular dysfunction, who was a poor surgi-
cal candidate and was undergoing high-risk coro-
nary intervention including left main stenting. Our 
patient had mild peripheral vascular disease noted 
during angiography, because iliac vessels were found 
free of the disease, the use of Impella device was not 
contraindicated. After successful PCI, when the 13 
Fr sheath placed for Impella device was removed, 
thrombus formation was noted on the same side in 
SFA  during  angiography. As  acute  thrombosis  of 
SFA  can  be  limb  threatening  and  would  required 
immediate  surgery  or  thrombolytic  therapy,  suc-
cessful thrombectomy and recovery of blood flow 
was  achieved  with  the  use  of  Pronto  V3  device. 
The  acute  thrombosis  was  likely  related  to  stasis 
and near complete occlusion of antegrade flow to 
the SFA secondary to a large sheath in ilio-femoral 
vasculature.
Pronto V3 is one of the thrombectomy devices, used 
with better outcomes in STEMI patients for perform-
ing thrombectomy before PCI.8 It has been used suc-
cessfully in management of acute stent thrombosis.9 
There are a few case reports of utilizing Pronto V3 in 
managing  non-coronary  vascular  thrombosis.10–12 
Ours is the first documented case utilizing Pronto V3 
thrombectomy device in managing acute superficial 
femoral artery thrombosis.
In  summary,  vascular  complications  such  as 
bleeding,  pseudo-aneurysm,  infections,  limb  isch-
emia and AV fistulas are always a possibility dur-
ing PCI especially when percutaneous assist devices 
with  bigger  sheaths  are  utilized  simultaneously. 
Extra caution has to be adopted in high-risk patients 
in particular patients with peripheral vascular disease. 
Even  though  these  local  vascular  complications 
have not been reported heavily, the interventional-
ist must be aware of their incidence and appropriate 
management.
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